Moderna will collaborate with Roche for the use of its COVID-19 antibody test as part of the company's ongoing coronavirus vaccine trials. The Roche assay previously received FDA emergency use authorization and will provide quantitative evidence to show that a response has been induced by Moderna's vaccine candidate in terms of antibody levels.